Shared on16 Sep 25Fair value Increased 2.92%
The consensus analyst price target for Mirion Technologies has increased modestly, while both the discount rate and future P/E ratio remain virtually unchanged, resulting in a slightly higher fair value estimate of $23.50. What's in the News Mirion Technologies entered into a strategic partnership with Westinghouse Electric to provide digital Ex-core Nuclear Instrumentation Systems, modernizing legacy neutron flux monitoring for global PWR operators.
Shared on27 Aug 25Fair value Increased 2.85%
Mirion Technologies' consensus price target has been revised upward, primarily reflecting a notable improvement in net profit margin and a substantial decline in future P/E, which together indicate stronger profitability and a more attractive valuation. What's in the News Mirion Technologies updated 2025 earnings guidance with higher expected revenue growth of 7.0%-9.0% (previously 5.0%-7.0%), factoring in FX and acquisition tailwinds; organic revenue growth revised to 5.0%-7.0% (previously 5.5%-7.5%).
Shared on04 Aug 25Fair value Increased 7.77%
The notable increase in Mirion Technologies’ future P/E and simultaneous decline in net profit margin suggest higher valuation expectations despite weaker profitability, leading analysts to raise the price target from $20.60 to $22.20. What's in the News Mirion Technologies raised full-year 2025 revenue growth guidance to 7.0%-9.0% (from 5.0%-7.0% prior), factoring in a foreign exchange and acquisition tailwind, but trimmed organic growth expectations due to weakness in Labs & Research and Dosimetry markets.
Shared on24 Apr 25Fair value Decreased 22%
AnalystConsensusTarget has increased shares outstanding growth rate from 0.0% to 0.1%.
Shared on17 Apr 25Fair value Decreased 5.15%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 2.04%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Increased 4.74%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.